Information for "Cycle One particular study of two substantial dosage intensity schedules of the panNotch inhibitor crenigacestat LY3039478 in conjunction with prednisone inside individuals together with sophisticated or even metastatic cancer"
From EECH Central
Basic information
| Display title | Cycle One particular study of two substantial dosage intensity schedules of the panNotch inhibitor crenigacestat LY3039478 in conjunction with prednisone inside individuals together with sophisticated or even metastatic cancer |
| Default sort key | Cycle One particular study of two substantial dosage intensity schedules of the panNotch inhibitor crenigacestat LY3039478 in conjunction with prednisone inside individuals together with sophisticated or even metastatic cancer |
| Page length (in bytes) | 3,569 |
| Page ID | 1323703 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Musicfly9 (Talk | contribs) |
| Date of page creation | 16:46, 31 March 2024 |
| Latest editor | Musicfly9 (Talk | contribs) |
| Date of latest edit | 16:46, 31 March 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
